The heat shock transcription factor 1 as a potential new therapeutic target in multiple myelomaTanja Heimberger(Comprehensive Cancer Center Mainfranken), Manik Chatterjee(Max Delbrück Center)British Journal of HaematologyDecember 18, 201210.1111/bjh.12164Cited by 65SaveCiteExport RISWatch citationsRelated PapersIn the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway|Blood|2002|100